A Study of Buntanetap in Participants With PD
for Parkinson's Disease (PD)
27 locations incl. Birmingham
Sponsor: Annovis Bio Inc.
Sex: All·Age: 40 - 85
Code: NCT07284784·Phase 2, Phase 3·Recruiting·Listed Dec 2025
Medical College of Wisconsin
Clinical research site in Milwaukee, Wisconsin · 9200 W WISCONSIN AVE, MILWAUKEE, WI 53226-3522 · (414) 805-6717 · Website
Part of Medical College of Wisconsin
As of July 2026, 226 paid clinical trials are recruiting at Medical College of Wisconsin in Milwaukee, Wisconsin. Active studies at this site cover conditions such as Acute Myeloid Leukemia, Stroke and Chronic Lymphocytic Leukemia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Medical College of Wisconsin (226)
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
28 locations incl. Little Rock
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07258511·Phase 3·Recruiting·Listed Dec 2025
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
for Breast Neoplasms
58 locations incl. Springdale
Sponsor: BioNTech SE
Sex: All·Age: 18+
Code: NCT07173751·Phase 3·Recruiting·Listed Sep 2025
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for Carcinoma, Non-Small-Cell Lung
86 locations incl. Huntsville
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06890598·Phase 3·Recruiting·Listed Mar 2025
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for Colorectal Neoplasms
68 locations incl. Chandler
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06750094·Phase 3·Recruiting·Listed Dec 2024
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
for Early Breast Cancer
85 locations incl. Birmingham
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT05827081·Phase 3·Recruiting·Listed Apr 2023
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for Lymphoma, Large B-Cell, Diffuse
71 locations incl. Mobile
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06890884·Phase 2·Recruiting·Listed Mar 2025
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
for NonSegmental Vitiligo
69 locations incl. Birmingham
Sponsor: Incyte Corporation
Sex: All·Age: 2 - 11
Code: NCT06548360·Phase 3·Recruiting·Listed Aug 2024
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for Metastatic Castration-resistant Prostate Cancer (mCRPC)
57 locations incl. Tucson
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06136650·Phase 3·Recruiting·Listed Nov 2023
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
for Antineutrophil Cytoplasmic Antibody-associated Vasculitis
57 locations incl. Scottsdale
Sponsor: Amgen
Sex: All·Age: 18 - 100
Code: NCT06072482·Phase 4·Recruiting·Listed Oct 2023
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
for Parkinson Disease
45 locations incl. Sun City
Sponsor: Neuron23 Inc.
Sex: All·Age: 40 - 80
Code: NCT06680830·Phase 2·Recruiting·Listed Nov 2024
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
for Tricuspid Regurgitation
46 locations incl. Irvine
Sponsor: Edwards Lifesciences
Sex: All·Age: 18+
Code: NCT04097145·Recruiting·Listed Sep 2019
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for Prostate Cancer
49 locations incl. Phoenix
Sponsor: Merck Sharp & Dohme LLC
Sex: Male·Age: 18+
Code: NCT06925737·Phase 3·Recruiting·Listed Apr 2025
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
for Progressive Pulmonary Fibrosis
74 locations incl. Birmingham
Sponsor: United Therapeutics
Sex: All·Age: 18+
Code: NCT05943535·Phase 3·Recruiting·Listed Jul 2023
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
for Metastatic Castration-resistant Prostate Cancer
48 locations incl. Birmingham
Sponsor: Celgene
Sex: Male·Age: 18+
Code: NCT06764485·Phase 3·Recruiting·Listed Jan 2025
A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
for Eosinophilic Esophagitis (EoE)
29 locations incl. Phoenix
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 1+
Code: NCT06693531·Recruiting·Listed Nov 2024
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
for Neoplasms
25 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 1 - 39
Code: NCT05999994·Phase 2·Recruiting·Listed Aug 2023
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
for Relapsing Multiple Sclerosis
40 locations incl. Scottsdale
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 40 - 70
Code: NCT06846281·Phase 3·Recruiting·Listed Feb 2025
Tracking Results of Ablations to Combat AF Registry Generation 2
for Atrial Fibrillation
26 locations incl. Huntsville
Sponsor: AtriCure, Inc.
Sex: All·Age: 18+
Code: NCT05111015·Recruiting·Listed Nov 2021
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for Pulmonary Hypertension Due to Lung Diseases and Hypoxia
66 locations incl. Birmingham
Sponsor: United Therapeutics
Sex: All·Age: 18+
Code: NCT06388421·Recruiting·Listed Apr 2024
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
for Mesial Temporal Lobe Epilepsy
35 locations incl. Birmingham
Sponsor: Neurona Therapeutics
Sex: All·Age: 18 - 75
Code: NCT05135091·Phase 3·Recruiting·Listed Nov 2021
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
for Pulmonary Embolism
55 locations incl. Long Beach
Sponsor: Penumbra Inc.
Sex: All·Age: 18+
Code: NCT04798261·Recruiting·Listed Mar 2021
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
for Relapsed Non-Hodgkin Lymphoma
32 locations incl. Irvine
Sponsor: Lyell Immunopharma, Inc.
Sex: All·Age: 18+
Code: NCT05826535·Phase 1, Phase 2·Recruiting·Listed Apr 2023
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
for Prostate Cancer
25 locations incl. Palo Alto
Sponsor: Novartis Pharmaceuticals
Sex: Male·Age: 18 - 100
Code: NCT06855277·Phase 3·Recruiting·Listed Mar 2025
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
for Prostate Cancer
27 locations incl. Los Angeles
Sponsor: Novartis Pharmaceuticals
Sex: Male·Age: 18 - 100
Code: NCT06780670·Phase 2, Phase 3·Recruiting·Listed Jan 2025
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
for Prostate Cancer Metastatic
31 locations incl. Palo Alto
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: All ages
Code: NCT06136624·Phase 3·Recruiting·Listed Nov 2023
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
for Small Cell Lung Cancer
30 locations incl. Springdale
Sponsor: Daiichi Sankyo
Sex: All·Age: 18+
Code: NCT06203210·Phase 3·Recruiting·Listed Jan 2024
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
for Multiple Myeloma
34 locations incl. Coral Gables
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT06215118·Phase 1·Recruiting·Listed Jan 2024
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for Graft-versus-host Disease (GVHD)
30 locations incl. Palo Alto
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT06615050·Phase 3·Recruiting·Listed Sep 2024
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
for cGVHD
31 locations incl. Birmingham
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT05919511·Recruiting·Listed Jun 2023
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
for Gastrointestinal Stromal Tumor (GIST)
32 locations incl. Birmingham
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06655246·Phase 1·Recruiting·Listed Oct 2024
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
for AAA - Abdominal Aortic Aneurysm
56 locations incl. Little Rock
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18+
Code: NCT06218875·Recruiting·Listed Jan 2024
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
for Extensive Stage-small Cell Lung Cancer
25 locations incl. Birmingham
Sponsor: Daiichi Sankyo
Sex: All·Age: 18+
Code: NCT06362252·Phase 1, Phase 2·Recruiting·Listed Apr 2024
A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury
for Traumatic Brain Injury
12 locations incl. Sacramento
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT07455136·Recruiting·Listed Mar 2026
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
for Myeloproliferative Neoplasms
22 locations incl. Birmingham
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT07441694·Phase 1·Recruiting·Listed Mar 2026
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
for Plaque Psoriasis
11 locations incl. Chula Vista
Sponsor: Takeda
Sex: All·Age: 4 - 17
Code: NCT07250802·Phase 3·Recruiting·Listed Nov 2025
A Long-term Follow-up Study in Patients Who Received BEAM-101
for Hemoglobinopathy
17 locations incl. Birmingham
Sponsor: Beam Therapeutics Inc.
Sex: All·Age: 14 - 37
Code: NCT07373639·Recruiting·Listed Jan 2026
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation
for Microvascular Inflammation
20 locations incl. Loma Linda
Sponsor: Biogen
Sex: All·Age: 18 - 74
Code: NCT07219043·Phase 2·Recruiting·Listed Oct 2025
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
for Aortic Arch Dissection
12 locations incl. Los Angeles
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18+
Code: NCT07166133·Recruiting·Listed Sep 2025
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
for Aortic Arch Aneurysm
21 locations incl. Birmingham
Sponsor: Artivion Inc.
Sex: All·Age: 18 - 80
Code: NCT07089576·Recruiting·Listed Jul 2025
Showing the 40 most relevant of 226 recruiting trials at this site. Browse all with filters →
More research sites in Milwaukee
- Aurora Sinai Medical Center (50 trials)
- Aurora Saint Luke's Medical Center (48 trials)
- Aurora Cancer Care-Milwaukee (46 trials)
- Children's Hospital of Wisconsin (44 trials)
- Froedtert & the Medical College of Wisconsin (21 trials)
- Children's Wisconsin (21 trials)
- Froedtert Hospital & the Medical College of Wisconsin (18 trials)
- Froedtert Hospital and the Medical College of Wisconsin (17 trials)
- Aurora St. Luke's Medical Center (15 trials)
- Froedtert Hospital (15 trials)
Explore more
Paid clinical trials in Milwaukee, WI · Wisconsin clinical trials